Published in Int J Pediatr on July 19, 2009
Flowcytometric immunophenotypic profile of acute leukemia: mansoura experience. Indian J Hematol Blood Transfus (2011) 0.81
Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia (1995) 4.04
Acute lymphoblastic leukemia. N Engl J Med (1998) 3.15
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood (2000) 2.92
Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood (1995) 2.89
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia (2000) 2.48
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. Leukemia (2000) 2.21
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia (2000) 1.94
Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood (1991) 1.74
Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA (2004) 1.56
Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood (1993) 1.47
Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol (1993) 1.36
Immunophenotyping of leukemia. J Immunol Methods (2000) 1.25
Immunophenotyping of acute leukemias and myelodysplastic syndromes. Cytometry A (2004) 1.13
Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data. Arch Pathol Lab Med (2003) 1.09
Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. Blood (1998) 1.09
Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood (1998) 1.02
Geographical distribution of acute lymphoblastic leukaemia subtypes: second report of the collaborative group study. Leukemia (1993) 0.99
Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood (1990) 0.95
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia. Best Pract Res Clin Haematol (2002) 0.94
Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia. Am J Hematol (2001) 0.89
Major hematologic diseases in the developing world- new aspects of diagnosis and management of thalassemia, malarial anemia, and acute leukemia. Hematology Am Soc Hematol Educ Program (2001) 0.89
Acute lymphoblastic leukaemia: diagnosis and classification. Best Pract Res Clin Haematol (2002) 0.84
Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP). Haematologica (1998) 0.84
Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. Am J Clin Pathol (1999) 0.84
Immunologic profile and outcome of childhood acute lymphoblastic leukemia (ALL) in Morocco. J Pediatr Hematol Oncol (2007) 0.81
A new approach of acute lymphoblastic leukemia immunophenotypic classification: 1984-1994 the GEIL experience. Groupe d'Etude Immunologique des Leucémies. Leuk Lymphoma (1994) 0.79
Analysis of the immunophenotypes of de novo acute lymphoblastic leukaemia (ALL) in the Sultanate of Oman. Leuk Res (2003) 0.77
Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco. BMC Public Health (2011) 1.34
Antimicrobial resistance monitoring in Neisseria gonorrhoeae and strategic use of funds from the Global Fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme. Sex Transm Infect (2013) 1.31
Influenza surveillance among outpatients and inpatients in Morocco, 1996-2009. PLoS One (2011) 1.05
2009 Pandemic influenza A virus subtype H1N1 in Morocco, 2009-2010: epidemiology, transmissibility, and factors associated with fatal cases. J Infect Dis (2012) 0.96
The genotypic population structure of Mycobacterium tuberculosis complex from Moroccan patients reveals a predominance of Euro-American lineages. PLoS One (2012) 0.95
[Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca]. Bull Cancer (2005) 0.94
Genetic diversity of TLR2, TLR4, and VDR loci and pulmonary tuberculosis in Moroccan patients. J Infect Dev Ctries (2014) 0.92
Phylogenetic analysis of rubella viruses found in Morocco, Uganda, Cote d'Ivoire and South Africa from 2001 to 2007. J Clin Virol (2008) 0.92
Treatment of Wilms tumor according to SIOP 9 protocol in Casablanca, Morocco. Pediatr Blood Cancer (2006) 0.91
Virological surveillance in Africa can contribute to early detection of new genetic and antigenic lineages of influenza viruses. J Infect Dev Ctries (2011) 0.89
Analysis of MIF, FCGR2A and FCGR3A gene polymorphisms with susceptibility to pulmonary tuberculosis in Moroccan population. J Genet Genomics (2010) 0.89
Pediatric rhabdomyosarcoma in Morocco. Pediatr Blood Cancer (2010) 0.88
Melanocortin-4 receptor gene mutations in a Dutch cohort of obese children. Obesity (Silver Spring) (2010) 0.88
Nutritional status at diagnosis of children with malignancies in Casablanca. Pediatr Blood Cancer (2008) 0.85
Rotavirus and norovirus infections among acute gastroenteritis children in Morocco. BMC Infect Dis (2014) 0.85
DNA barcodes confirm the presence of a single member of the Anopheles maculipennis group in Morocco and Algeria: An. sicaulti is conspecific with An. labranchiae. Acta Trop (2010) 0.85
The MCP-1 (CCL2) -2518 GG genotype is associated with protection against pulmonary tuberculosis in Moroccan patients. J Infect Dev Ctries (2012) 0.82
[Retinoblastoma: inventory in Mali and program to develop early diagnosis, treatments and rehabilitation]. Bull Cancer (2013) 0.79
Genotypic correlation between six common beta-thalassemia mutations and the XmnI polymorphism in the Moroccan population. Hemoglobin (2007) 0.79
Ovarian tumours in children : a review of 18 cases. Afr J Paediatr Surg (2012) 0.78
MICA polymorphism in a population from north Morocco, Metalsa Berbers, using sequence-based typing. Hum Immunol (2005) 0.78
Sequence-Based analysis of the HLA-DRB1 polymorphism in Metalsa Berber and Chaouya Arabic-speaking groups from Morocco. Hum Immunol (2002) 0.77
Outcomes in patients with mixed phenotype acute leukemia in Morocco. J Pediatr Hematol Oncol (2014) 0.77
Metastatic neuroblastoma to the mandible in a 3-year-old boy: a case report. Med Oral Patol Oral Cir Bucal (2007) 0.77
Combined factor V and VIII deficiency and pregnancy. Int J Hematol (2012) 0.76
Antimicrobial resistance in Salmonella enterica serovar Enteritidis in Morocco. J Infect Dev Ctries (2010) 0.75
Improving the prognosis of pediatric Hodgkin lymphoma in developing countries: a Moroccan Society of Pediatric Hematology and Oncology study. Pediatr Blood Cancer (2013) 0.75
[A hemophagocytic syndrome revealing a Griscelli syndrome type 2]. Ann Biol Clin (Paris) (2013) 0.75
Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection. Tuberculosis (Edinb) (2009) 0.75
[Healthcare-associated infections in a paediatric haematology/oncology unit in Morocco]. Sante Publique (2014) 0.75
Infections in hospitalized children and young adults with acute leukemia in Morocco. Pediatr Blood Cancer (2013) 0.75
High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data. Diagn Mol Pathol (2013) 0.75